LIQUAMYCIN LA-200 is approved for: • The treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida; and leptospirosis caused by Leptospira pomona.
• In sows, LIQUAMYCIN LA-200 is indicated as an aid in the control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.
Discontinue treatment with LIQUAMYCIN LA-200 at least 28 days prior to slaughter. Discard milk for 96 hours after the last treatment. Do not exceed the highest recommended level of drug per lb of body weight per day.
IMPORTANT SAFETY INFORMATION: Withdraw LIQUAMYCIN LA-200 at least 28 days prior to slaughter.